hVIVO

Influenza field study contract

  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 27.0p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

DAVY VIEW

Following on from the milestone Omicron contract win announced last month, hVIVO has announced its largest ever field study contract to test an influenza drug candidate, which will involve enrolling up to 1,000 healthy volunteers. The company will also host a Capital Markets Day on July 17th.

Download full report with analyst certification and important disclosures

Jul 2 2024, 08:05 IST/BST

Download